Some authors reported about Ca2+-ATPase activity of erythrocyte membranes decreased in both diabetes [47,48] and in erythrocytes treated ex vivo with glucose [49], probably due to the glycation of Ca2+-ATPase [50,51]. The gene discussed is CA2; the disease is diabetes mellitus.